Raquel Cristine Silva Barcelos, Dalila Moter Benvegnú, Nardeli Boufleur, Patrícia Reckziegel, Liz Girardi Müller, Camila Pase, Tatiana Emanuelli, Marilise Escobar Bürger
Index: Neurotox. Res. 17(3) , 228-37, (2010)
Full Text: HTML
The effects of fish oil supplementation on motor disorders, memory dysfunction, and lipid peroxidation (LP) induced by typical neuroleptics were studied. Wistar rats received a suspension prepared with fish oil containing omega-3 fatty acids, water, and Tween 80 (1%) in the place of drinking water (FO group) or vehicle (C group) for 8 weeks. After 4 weeks of treatment, half of the animals of both groups were treated with haloperidol (H and FO + H groups; experiment 1), fluphenazine (F and FO + F groups; experiment 2), or vehicle (C group), administered once a week (12 mg/kg/im) for 4 weeks, maintaining the treatment with FO. Extrapyramidal motor disorders by haloperidol and fluphenazine were observed by an increase in vacuous chewing movements and catalepsy (P < 0.05). These effects were reduced by FO treatment (P < 0.05). Both neuroleptics displayed impairment in memory retention observed by latency time to find the original location of platform in water-maze task, after 4 days of training performed in the last treatment week. This effect was reduced by FO (P < 0.05) to both haloperidol and fluphenazine treatments. Haloperidol increased the LP in plasma and hippocampus, and these effects were decreased by FO treatment (P < 0.05). Fluphenazine increased the LP in plasma and substantia nigra, which were completely decreased by FO treatment (P < 0.05). The FO decreased the motor disorders, memory dysfunction, and oxidative damage typical neuroleptic-induced. Our results indicate that FO exhibits a neuroprotector role useful on diseases related to oxidative damages, and may be considered in the prevention of motor and memory side effects induced by the antipsychotic treatment.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate
CAS:74050-97-8 |
C31H41ClFNO3 |
Effectiveness of paliperidone palmitate vs haloperidol decan...
2014-05-21 [JAMA 311(19) , 1978-87, (2014)] |
Maintenance treatment with long-acting injectable antipsycho...
2014-05-21 [JAMA 311(19) , 1973-4, (2014)] |
Ten year outcomes of outpatients with schizophrenia on conve...
2013-09-01 [Int. Clin. Psychopharmacol. 28(5) , 261-6, (2013)] |
Prospective trial of customized adherence enhancement plus l...
2013-12-01 [J. Clin. Psychiatry 74(12) , 1249-55, (2013)] |
Differing effects of antipsychotic medications on substance ...
2006-01-01 [Am. J. Addict. 15(2) , 166-73, (2006)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved